// App-Quantinova.ai

: THE BRIGHT RANDOMISED STUDY: SIMILAR GLYCAEMIC CONTROL AND LESS CONFIRMED HYPOGLYCAEMIA WITH GLA-300 VS IDEG-100 DURING THE INITIAL TITRATION PERIOD

Researchers

Presenter

  • Ritzel R

Principal Investigators

  • Cheng A

  • Rosenstock J

  • Bosnyak Z

  • Devisme C

  • Stella P

  • Cali A.M.G

  • Wang X

  • Frias J

  • Roussel R

  • Bolli G.B

Medical Centers

  • National Research Institute, Los Angeles, California, United States

  • AIXIAL, Biostatistics and Programming, Boulogne-Billancourt, France

  • University of Toronto, Division of Endocrinology and Metabolism, Toronto, Canada

  • Sanofi, Budapest, Budapest, Hungary

  • Sanofi, Tokyo, Tokyo, Japan

  • Städtisches Klinikum München GmbH, Klinikum Schwabing and Klinikum Bogenhausen, Munich, Germany

  • Dallas Diabetes Research Center, Medical City, Dallas, USA

  • Pisa University School of Medicine, Pisa, Italy

  • Assistance Publique des Hôpitaux de Paris, Cochin Hospital, Paris, France

  • Sanofi, Paris, Paris, France

  • Stanford, Beijing, Beijing, China

Locations

  • United States

  • France

  • Canada

  • Hungary

  • Japan

  • Germany

  • Italy

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • AT-rich interactive domain 3A

  • Hemoglobin A1c

Drug/Treatment

  • Insulin glargine

  • Insulin degludec

Outcome

  • N/A

Study Design

  • Randomized

  • Open Label

  • Multiple Arm

  • Multinational

  • Multicenteric

  • Parallel Group

Phase

  • NA

Study Id's

  • NCT02738151

Sponsors

  • Sanofi

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved